News

The ultimate goal in the biopharma space, especially for vaccine manufacturers, is producing safe and effective therapies faster, and at a lower cost. Many professionals still believe that their competitive edge relies on technical improvement, but it’s more complicated than that…

In response to the outbreak, governments around the world have put strict measures in place to limit the spread of the virus – Italy was the first country to order a country-wide lock down, France closed its borders and PM…

In recent years, gene therapies, gene-modified cell therapies and cell therapies, collectively known as ‘Advanced Therapies’, have rapidly become an integral part of the R&D programs of many Biopharmaceutical companies. This is illustrated by some of the key trends…

Western CROs continue to up their game. They are offering unique services in a marketplace where the big CROs of the east are providing an unsurpassed scale of resourcing to support the externalization of discovery services. I believe there is…

Want to know a secret? In September we hosted a very large group of IDBS customers from the US at i3 Nashville. Customers from every R&D industry sharing experiences, lessons learned, and business challenges. So, are you going to…

We sat down with Chelsea Hyde, Field Marketing Manager for North America at IDBS, to find out what i3 means to IDBS, and what to expect at future events.   What does i3 mean? When we were coming up with…

We sat down with Christian Marcazzo, General Manager at IDBS, to find out what the benefits of attending i3 are, and how it fits into his vision for IDBS. What are some of the benefits to customers attending the i3…

The biopharmaceutical industry continues to grow and isn’t showing any signs of slowing down. Last year, we talked about different aspects of the biopharmaceutical industry. These touched on several trends from the importance of data and the extensive use…

We sat down with J.T. Kaminski, Customer Success Manager at IDBS, to find out what i3 means to IDBS, and what he sees for the event’s future.   What’s the most eye-opening thing you’ve seen at i3 last year? I’d…

Eighty-five. That’s the number of warning letters the FDA issued in 2018 alone. And of those letters, 49% were surrounding data integrity. This highlights a serious issue: there are data integrity deficiencies in the lab environment. With so many warning…

We sat down with Brady Haggstrom, Product Manager at IDBS, to find out what i3 means, and its highlights.   What do you look forward to most about coming to i3 events? I look forward most to talking with customers and hearing about their challenges, what…

In our last blog post, we took a dive into the 2019 draft of the ICH M10 Bioanalytical Method Validation Guideline, the changes made, and how they affect scientists working at the bench. In this follow-up post, we’ll see…

The International Council of Harmonisation (ICH) has released a draft new guidance for bioanalytical method validation, and it has created quite a buzz, exemplified in a webinar hosted by Bioanalysis Zone. A panel of experts came together to discuss…

Historically, small molecule pharmaceutical products dominated the medical drugs market, from treatments for diabetes to broad-spectrum antibiotics, they worked, and the pharma industry bloomed. However, in today’s day and age, as the prevalence of different types of diseases and…

The importance of data integrity The research and development (R&D) industry has a responsibility to ensure the drugs they produce are safe, effective and high quality, and data integrity is key to making that happen. But it’s not always…

When you think of a medication, is the active ingredient the first thing that pops into your head, or perhaps the name of the drug? You’re not alone. The active ingredient of a medicine gets all the attention, which…

Science is based on evidence, but the scientific research field is facing a reproducibility crisis. The science journal Nature published a survey in 2016, which demonstrated more than 70% of researchers could not replicate their peers’ studies in well-controlled…

Getting a product to market has always been a challenge. Discovering something new is just the beginning. After that, there’s the issue of securing the funding to bring the idea to life – the research, manufacturing processes, and pushing it…

The biologics market – medicines made from biological living systems through biotechnology – is trending. There’s no doubt about that.   And the numbers back it up. According to a report by Market Research Future, the global biologics market…

Organizations in the biologics landscape face several challenges in the race to get their product to market, including handling their data efficiently. We have a solution…   Industry growth presents challenges The continued growth in the biologics sector has…

When one thinks of the pharma and biopharma markets, one thing stands out – growth. In recent years, driven by necessity, advances in technology and ultimately funding, there has been a focused effort to transform our approach to medicine…

E-WorkBook is an electronic lab notebook that forms part of the IDBS cloud-based solution to manage your scientific data. Designed to replace the traditional paper lab notebook, information is stored electronically and so can be accessed and searched effortlessly…

We are just two weeks away from our Early Bird deadline for tickets to our i3 events in Nashville and London this year. Book before 31st May and you’ll get 40% off our Standard or All Access Passes. Don’t…

The biologics landscape is modern and ever-changing – and it needs innovative solutions to keep up with growing demand. What’s needed is a far-reaching and comprehensive solution, that helps scientists effortlessly execute workflows and provides decision-driving insight. We…

Without heavy investment in research and development (R&D), the millions of new and innovative medical technologies, drugs and delivery systems developed each year would simply not happen. In 2018, the UK’s medical funding body – the Medical Research Council…

In this expert interview, Debbie Barklamb, Account Manager with IDBS, explains how she works with our customers, coordinating resources to help them successfully onboard IDBS software. This includes helping new customers adopt and roll out our software and ensuring…